文献速递慢病管理

基层医疗中基础胰岛素的起始与剂量调整:障碍与实用解决方案

Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions.
PubMed 文献 · J Am Board Fam Med · 2019-01-01

本文综述了2型糖尿病管理中基础胰岛素起始与剂量调整的策略,重点介绍第二代基础胰岛素的特点与滴定方法,并结合现行指南提出识别和克服胰岛素治疗障碍的建议。文章指出,基层医生常因时间、患者接受度、低血糖担忧及过时观念而延迟起始胰岛素,可通过团体教育、移动技术和社区糖尿病教育者等途径应对。

要点

  • 基础胰岛素治疗常被延迟或回避,导致不必要的高血糖和更差结局。
  • 基层医生犹豫的原因包括时间投入、患者接受度、注射与滴定能力及低血糖恐惧。
  • 团体课程、移动技术和社区糖尿病教育者可缓解时间顾虑,正确滴定与第二代基础胰岛素可减少低血糖和体重增加。

核心结论

  • 基础胰岛素是许多2型糖尿病患者有效管理的关键部分,但起始和滴定常被延迟或回避。
  • 对基础胰岛素的抵触与不必要的高血糖和更差的患者结局相关。

研究设计与样本

  • 本文为综述,回顾基础胰岛素治疗起始策略,重点介绍第二代基础胰岛素的特征与滴定,并介绍现行指南。

主要发现

  • 基层医生常因教育患者所需时间或精力、对患者接受度或管理滴定/注射能力的怀疑、或患者对低血糖的恐惧而犹豫起始基础胰岛素。
  • 对基础胰岛素治疗的抵触常与过时观念有关,即认为需要胰岛素代表疾病控制失败,或认为胰岛素危险或有毒。
  • 时间顾虑可通过团体课程和移动技术以及与社区糖尿病教育者合作来解决。
  • 低血糖或体重增加可通过正确滴定和使用第二代基础胰岛素来最小化。

临床怎么用

  • 基层医生应与患者密切合作,讨论和管理向基础胰岛素治疗的过渡。
  • 可通过团体课程、移动技术和社区糖尿病教育者应对时间顾虑。
  • 应使用正确滴定和第二代基础胰岛素以最小化低血糖和体重增加。
  • 应识别并克服患者和医生对胰岛素治疗的过时观念与障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Basal insulin therapy is a critical part of effective type 2 diabetes (T2D) management for many patients, yet its initiation and titration are often delayed or avoided. Aversion to basal insulin therapy contributes to unnecessary hyperglycemia and poorer outcomes for patients. Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy. However, many primary care clinicians hesitate to initiate basal insulin due to concerns regarding time or effort needed to educate patients, doubts about patient acceptance or ability to manage titration or injection, or patient fears of hypoglycemia. Resistance to basal insulin therapy is often linked to the outdated perception that the need for insulin represents a failure to control the disease, or that insulin is dangerous or toxic. Time concerns can be addressed via group classes and mobile technology and by working with diabetes educators in the community. Hypoglycemia or weight gain can be minimized with proper titration and use of second-generation basal insulins. This article reviews strategies for the initiation of basal insulin therapy, with an emphasis on the characteristics and titration of second-generation basal insulins, introducing current guidelines and offering suggestions for recognizing and overcoming barriers to insulin therapy in the management of T2D.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Perreault L, Vincent L, Neumiller JJ, et al. Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions. J Am Board Fam Med. 2019. PMID: 31068410. doi:10.3122/jabfm.2019.03.180162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。